Insider · CIK 0001971303
Kevin M. Brennan
officer
Files at XLO (Xilio Therapeutics, Inc.). First filing Jan 3, 2025, latest Jan 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1,774 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XLO: Xilio Therapeutics, Inc.
XLOOct 9, 2026 · close 9.05
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Xilio Therapeutics, Inc. | $1,774 1,803 shares | -36% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 1, 2025 | XLO Xilio Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | - | - | 5,000 | Jan 3, 2025 |
| Jan 2, 2025 | XLO Xilio Therapeutics, Inc. | SOpen-market sale Common stock10b5-1 | -1,803 | $0.98 | $1,774 | 3,197 | Jan 3, 2025 |
| Jan 1, 2025 | XLO Xilio Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -5,000 | $0.00 | $0 | 15,000 | Jan 3, 2025 |
| Jan 1, 2025 | XLO Xilio Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +60,000 | $0.00 | $0 | 60,000 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.